We are currently enrolling in studies for Myasthenia Gravis.
Please contact Lupe at 619-432-0954.
Descartes-08 CAR-T Cells In Generalized Myasthenia Gravis (MG).https://clinicaltrials.gov/ct2/show/NCT04146051
A Phase 3, Multi-center, Randomized, Quadruple‑blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG).https://clinicaltrials.gov/ct2/show/NCT05403541?id=IMVT+1401-3101&draw=2&rank=1
FLEX Research Study for Adults with Generalized Myasthenia Gravis (gMG)
The FLEX study is a randomized, blinded, and placebo-controlled study assessing the efficacy and safety of an investigational drug for adults diagnosed with gMG. The injectable investigational drug is being evaluated over a 12-week induction period and a 12-week maintenance period. Based on completion of these periods and a participant’s response to the investigational drug, participation in a 52-week extension study of the investigational drug may be available to study participants. To learn more, please contact <<contact info>> www.gMG-research.com